Kairos Pharma, LTD. has filed 118 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-22 | Entry into a Material Definitive Agreement; Other Events |
| 8-K | 2026-07-15 | Other Events; Financial Statements and Exhibits |
| 8-K | 2026-06-30 | Submission of Matters to a Vote of Security Holders |
| 8-K | 2026-06-04 | Other Events; Financial Statements and Exhibits |
| DEFA14A | 2026-05-26 | Additional Proxy Soliciting Materials |
| DEF 14A | 2026-05-22 | Proxy Statement |
| 8-K | 2026-05-18 | Other Events; Financial Statements and Exhibits |
| 10-Q | 2026-05-13 | Quarterly Report |
| PRE 14A | 2026-05-11 | Preliminary Proxy Statement |
| 424B3 | 2026-04-01 | 424B3 |